Stay updated on ELVN-001 for CML Treatment Clinical Trial
Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check13 days agoChange DetectedThe page has been updated to reflect an increase in the number of study locations from 42 to 46, with new recruiting sites added in Warsaw, Budapest, Leuven, and the Bronx, along with updated contact information for key personnel.SummaryDifference4%
- Check20 days agoChange DetectedThe page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours. The previous mention of an estimated last update has been removed.SummaryDifference2%
- Check27 days agoChange DetectedThe web page has been updated to reflect an increase in the number of study locations from 39 to 42, and it now includes new contact information for several recruiting sites in the UK, Hungary, and Belgium. Additionally, there are updates to the eligibility criteria for patients regarding treatment options for CML.SummaryDifference8%
- Check41 days agoChange DetectedThe page now indicates that the ClinicalTrials.gov data ingest is expected to be modernized in July 2025, with an increase in the number of study locations from 35 to 39. Additionally, several new contact details for recruiting sites in Poland, the Netherlands, Italy, and Belgium have been added.SummaryDifference4%
- Check48 days agoChange DetectedThe web page has been updated to a new version, v2.16.3, replacing the previous version v2.16.2.SummaryDifference0.1%
Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.